28664 Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: American 

Radiolabeled Chem 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 20, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on March 

13, 2018, American Radiolabeled Chem, 

101 Arc Drive, St. Louis, MO 63146 

applied to be registered as a bulk 

manufacturer of the following basic 

classes of controlled substances: 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ................................................................................................................................... 2010 I 

Ibogaine ................................................................................................................................................................... 7260 I 

Lysergic acid diethylamide ...................................................................................................................................... 7315 I 

Tetrahydrocannabinols ............................................................................................................................................ 7370 I 

Dimethyltryptamine .................................................................................................................................................. 7435 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................... 7470 I 

Dihydromorphine ...................................................................................................................................................... 9145 I 

Heroin ...................................................................................................................................................................... 9200 I 

Normorphine ............................................................................................................................................................ 9313 I 

Amphetamine ........................................................................................................................................................... 1100 II 

Methamphetamine ................................................................................................................................................... 1105 II 

Amobarbital .............................................................................................................................................................. 2125 II 

Phencyclidine ........................................................................................................................................................... 7471 II 

Phenylacetone ......................................................................................................................................................... 8501 II 

Cocaine .................................................................................................................................................................... 9041 II 

Codeine .................................................................................................................................................................... 9050 II 

Dihydrocodeine ........................................................................................................................................................ 9120 II 

Oxycodone ............................................................................................................................................................... 9143 II 

Hydromorphone ....................................................................................................................................................... 9150 II 

Ecgonine .................................................................................................................................................................. 9180 II 

Hydrocodone ............................................................................................................................................................ 9193 II 

Meperidine ............................................................................................................................................................... 9230 II 

Metazocine ............................................................................................................................................................... 9240 II 

Methadone ............................................................................................................................................................... 9250 II 

Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II 

Morphine .................................................................................................................................................................. 9300 II 

Oripavine .................................................................................................................................................................. 9330 II 

Thebaine .................................................................................................................................................................. 9333 II 

Oxymorphone .......................................................................................................................................................... 9652 II 

Phenazocine ............................................................................................................................................................ 9715 II 

Carfentanil ................................................................................................................................................................ 9743 II 

Fentanyl ................................................................................................................................................................... 9801 II 

The company plans to manufacture 

small quantities of the above-listed 

controlled substances as radiolabeled 

compounds for biochemical research. 

Dated: June 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–13231 Filed 6–19–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Cerilliant 

Corporation 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 20, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 28665 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

delegated to the Assistant Administrator 

of the DEA Diversion Control Division 

(‘‘Assistant Administrator’’) pursuant to 

section 7 of 28 CFR part 0, appendix to 

subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on May 

4th, 2018, Cerilliant Corporation, 811 

Paloma Drive, Suite A, Round Rock, 

Texas 78665 applied to be registered as 

a bulk manufacturer of the following 

basic classes of controlled substances: 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. 1233 I 

Cathinone ........................................................................................................................................................................ 1235 I 

Methcathinone ................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. 1238 I 

Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... 1249 I 

Naphyrone ....................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ....................................................................................................................................................... 1475 I 

N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I 

Fenethylline ..................................................................................................................................................................... 1503 I 

Aminorex .......................................................................................................................................................................... 1585 I 

4-Methylaminorex (cis isomer) ........................................................................................................................................ 1590 I 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................. 2565 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ................................................................................................... 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) ................................................. 7008 I 

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7010 I 

5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................ 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I 

MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................... 7020 I 

FUB–AMB, MMB-Fubinaca 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate ............................... 7021 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I 

THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................... 7024 I 

AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................. 7031 I 

MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 7032 I 

5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 7033 I 

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...... 7034 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I

MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- 

dimethylbutanoate).

7042 I 

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I 

5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .................................. 7049 I 

JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 7081 I 

SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) .................................................................... 7104 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I 

JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) ...................................................................................................... 7122 I 

UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. 7144 I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7173 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) ........................................................................................................ 7201 I 

JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) ....................................................................................................... 7203 I 

PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 7222 I 

5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 7225 I 

Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... 7298 I 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .............................................................................................. 7348 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Parahexyl ......................................................................................................................................................................... 7374 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) ........................................................................................... 7385 I 

3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) ....................................................................................................... 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 7399 I 

3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 


sradovich on DSK3GMQ082PROD with NOTICES
28666 Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 

Controlled substance Drug code Schedule 

4-Methoxyamphetamine .................................................................................................................................................. 7411 I 

5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ 7431 I 

Alpha-methyltryptamine ................................................................................................................................................... 7432 I 

Bufotenine ........................................................................................................................................................................ 7433 I 

Diethyltryptamine ............................................................................................................................................................. 7434 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

Psilocybin ......................................................................................................................................................................... 7437 I 

Psilocyn ........................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I 

N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I 

N-Benzylpiperazine .......................................................................................................................................................... 7493 I 

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 7498 I 

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .................................................................................................. 7508 I 

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) .................................................................................................... 7509 I 

2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ................................................................................................................. 7517 I 

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................ 7518 I 

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .................................................................................................. 7519 I 

2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) .................................................................................................... 7521 I 

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ............................................................................................. 7524 I 

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) .................................................................................. 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I 

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) .................................................... 7536 I 

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) .................................................... 7537 I 

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ......................................................... 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I 

Butylone ........................................................................................................................................................................... 7541 I 

Pentylone ......................................................................................................................................................................... 7542 I 

alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I 

AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) .................................................................................................... 7694 I 

Acetyldihydrocodeine ....................................................................................................................................................... 9051 I 

Benzylmorphine ............................................................................................................................................................... 9052 I 

Codeine-N-oxide .............................................................................................................................................................. 9053 I 

Desomorphine ................................................................................................................................................................. 9055 I 

Codeine methylbromide ................................................................................................................................................... 9070 I 

Dihydromorphine ............................................................................................................................................................. 9145 I 

Heroin .............................................................................................................................................................................. 9200 I 

Hydromorphinol ............................................................................................................................................................... 9301 I 

Methyldesorphine ............................................................................................................................................................ 9302 I 

Methyldihydromorphine ................................................................................................................................................... 9304 I 

Morphine methylbromide ................................................................................................................................................. 9305 I 

Morphine methylsulfonate ............................................................................................................................................... 9306 I 

Morphine-N-oxide ............................................................................................................................................................ 9307 I 

Normorphine .................................................................................................................................................................... 9313 I 

Pholcodine ....................................................................................................................................................................... 9314 I 

U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. 9547 I 

AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) ................................................................... 9551 I 

MT45 ................................................................................................................................................................................ 9560 I 

Acetylmethadol ................................................................................................................................................................ 9601 I 

Allylprodine ...................................................................................................................................................................... 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I 

Alphameprodine ............................................................................................................................................................... 9604 I 

Alphamethadol ................................................................................................................................................................. 9605 I 

Betacetylmethadol ........................................................................................................................................................... 9607 I 

Betameprodine ................................................................................................................................................................ 9608 I 

Betamethadol ................................................................................................................................................................... 9609 I 

Betaprodine ..................................................................................................................................................................... 9611 I 

Dipipanone ....................................................................................................................................................................... 9622 I 

Hydroxypethidine ............................................................................................................................................................. 9627 I 

Noracymethadol ............................................................................................................................................................... 9633 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Normethadone ................................................................................................................................................................. 9635 I 

Trimeperidine ................................................................................................................................................................... 9646 I 

Phenomorphan ................................................................................................................................................................ 9647 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 9661 I 

Tilidine ............................................................................................................................................................................. 9750 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. 9811 I 

Para-Fluorofentanyl ......................................................................................................................................................... 9812 I 

3-Methylfentanyl .............................................................................................................................................................. 9813 I 

Alpha-methylfentanyl ....................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ............................................................................................................................................. 9815 I 

Orthofluorofentanyl N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4yl)propionamide ......................................................... 9816 I 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 28667 

Controlled substance Drug code Schedule 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... 9821 I 

Butyryl Fentanyl ............................................................................................................................................................... 9822 I 

Para-Fluorobutyrl Fentanyl .............................................................................................................................................. 9823 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... 9824 I 

Methoxyacetyl Fentanyl 2-methoxy-N-(1-phenethylpiperidin-4-yl)-Nphenylacetamide ................................................... 9825 I 

Para-Chloroisobutyrl Fentanyl ......................................................................................................................................... 9826 I 

Isobutyryl Fentanyl .......................................................................................................................................................... 9827 I 

Beta-hydroxyfentanyl ....................................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl ................................................................................................................................................. 9832 I 

3-Methylthiofentanyl ......................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. 9834 I 

Thiofentanyl ..................................................................................................................................................................... 9835 I 

Beta-hydroxythiofentanyl ................................................................................................................................................. 9836 I 

Para-methoxybutyryl fentanyl .......................................................................................................................................... 9837 I 

Ocfentanil ......................................................................................................................................................................... 9838 I 

Valeryl Fentanyl ............................................................................................................................................................... 9840 I 

Tetrahydrofuranyl Fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran2-carboxamide ............................... 9843 I 

Cyclopropyl Fentanyl ....................................................................................................................................................... 9845 I 

Cyclopentyl fentanyl ........................................................................................................................................................ 9847 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ..................................................................................... 9850 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Methamphetamine ........................................................................................................................................................... 1105 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Phenmetrazine ................................................................................................................................................................. 1631 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Amobarbital ...................................................................................................................................................................... 2125 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

Secobarbital ..................................................................................................................................................................... 2315 II 

Glutethimide ..................................................................................................................................................................... 2550 II 

Nabilone ........................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ................................................................................................................................................ 7460 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... 8333 II 

1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ 8603 II 

Alphaprodine .................................................................................................................................................................... 9010 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Diphenoxylate .................................................................................................................................................................. 9170 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Ethylmorphine .................................................................................................................................................................. 9190 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levomethorphan .............................................................................................................................................................. 9210 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Isomethadone .................................................................................................................................................................. 9226 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-A .............................................................................................................................................. 9232 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Meperidine intermediate-C .............................................................................................................................................. 9234 II 

Metazocine ...................................................................................................................................................................... 9240 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Thiafentanil ...................................................................................................................................................................... 9729 II 

Racemethorphan ............................................................................................................................................................. 9732 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Fentanyl ........................................................................................................................................................................... 9801 II 


sradovich on DSK3GMQ082PROD with NOTICES
28668 Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to its 

customers. 

Dated: June 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–13221 Filed 6–19–18; 8:45 am] 

BILLING CODE 4410–09–P 

NATIONAL SCIENCE FOUNDATION 

Request for Information— 

Environmental Research and 

Education, National Security, and 

Economic Competitiveness 

AGENCY: National Science Foundation. 

ACTION: Notice of Request for 

Information. 

SUMMARY: The purpose of this Request 

for Information (RFI) is to seek input 

from the public on possible future 

directions for fundamental 

environmental science and education. 

The RFI intends to gather views from 

external stakeholders on what 

environmental research and education 

is needed to further advance national 

security and economic competitiveness. 

NSF’s Advisory Committee for 

Environmental Research and Education 

(AC ERE) will use the input to develop 

a report on these topics to inform NSF 

and the community. 

DATES: Written comments must be 

submitted by August 20, 2018. 

ADDRESSES: Responses will be 

submitted via online survey (https://

www.surveymonkey.com/r/ACERE-RFI2018). See the instructions in the 

SUPPLEMENTARY INFORMATION for 

guidelines. 

FOR FURTHER INFORMATION CONTACT: 

Contact Leah Nichols, Executive 

Secretary for the AC ERE, at lenichol@

nsf.gov for further information. 

SUPPLEMENTARY INFORMATION: The 

National Science Foundation’s Advisory 

Committee for Environmental Research 

and Education (AC ERE) invites your 

input on possible environmental 

research and education directions to 

further advance national security and 

economic competitiveness. The purpose 

of the AC ERE is to: 

• Provide advice, recommendations 

and oversight concerning support for 

the NSF’s environmental research and 

education portfolio; 

• Be a base of contact with the 

scientific community to inform NSF of 

the impact of its research support and 

NSF-wide policies on the scientific 

community; 

• Serve as a forum for consideration 

of interdisciplinary environmental 

topics as well as environmental 

activities in a wide range of disciplines; 

• Provide broad input into long-range 

plans and partnership opportunities; 

and 

• Provide advice about program 

management, overall program balance, 

and other aspects of program 

performance for environmental research 

and education activities. 

The Committee has been interested 

broadly in fundamental environmental 

research and education that also has 

societal utility. It has recently focused 

its attention on two major topics where 

there is broad consensus on the 

importance of the research to date, but 

where significant research questions 

remain. These topics are at the nexus of 

environmental science and engineering 

with economic growth and 

competitiveness, and the relationship of 

environmental factors to national and 

human security. The Committee is 

particularly interested in approaches 

that promote convergent research across 

disciplines and sectors to address 

economic competitiveness and 

economic security. 

To identify emerging research 

questions in these areas, the committee 

is reaching out to interested and 

knowledgeable members of the 

scientific community in all disciplines 

and interdisciplinary areas for their 

views. The AC ERE is also interested in 

the views of professionals who are 

directly involved in decision-making or 

operational activities in these areas, and 

who therefore can provide a very 

practical perspective on high-priority 

research and education topics. 

The AC ERE invites individuals and 

groups of individuals to provide input 

on one or both of the topics described 

above via this link: https://

www.surveymonkey.com/r/ACERE-RFI2018. 

The online submission form requires 

the following information: 

1. Author name(s) and affiliation(s); 

2. Valid contact email address; 

3. Title of the response; 

4. An abstract (200 words or less) 

summarizing the response; and 

5. Checkbox to consent to allow the 

AC ERE to display the submitted 

information, consistent with the 

Creative Commons AttributionNonCommercial-NoDerivatives 4.0 

International License (https://

creativecommons.org/licenses/by-nc-nd/ 

4.0/legalcode). 

You will also be asked to identify 

whether your response focuses on 

questions in environmental research 

and education that are pertinent to (a) 

economic growth and competitiveness, 

(b) national and human security, or (c) 

both topics. The submission form 

includes the following question 

prompts. Respondents may respond to 

all or any subset of these questions. 

• What are the major environmental 

research priorities with the greatest 

potential to contribute to economic 

growth and competitiveness and/or 

national or human security/wellbeing? 

Priorities could, for example, include 

empirical, theoretical, or qualitative 

analyses, establishing baselines, and/or 

experimental studies. (500 words or 

less) 

• What methodologies should be used 

for conducting such studies? 

Methodological recommendations could 

include the prospects for 

interdisciplinary and/or convergent 

research approaches, including 

modeling, theory, empirical, qualitative, 

and/or experimental studies. 

Methodological recommendations could 

also discuss the scope of studies, e.g. the 

balance between single-investigator 

studies and large teams. (500 words or 

less) 

• What education (including formal 

and informal), research, and training 

opportunities—for students, 

postdoctoral researchers, and mid-career 

scientists—are needed? Opportunities 

might include interdisciplinary, teambased, or other innovative, value-added 

strategies for realizing higher levels of 

depth and breadth at the individual 

level, and/or expansion of the current 

environmental research community 

through inclusion of currently underrepresented groups. (500 words or less) 

• Beyond economic competitiveness 

and national security, what other high 

priority drivers of environmental 

science and education need attention? 

(200 words or less) 

Submissions must be received by 5:00 

p.m. Eastern Time on August 20, 2018. 

Respondents may edit their responses 

while completing the survey, but will 

not be able to save work in progress to 

complete later. Respondents will see a 

confirmation screen upon successful 

submission responses. 

The committee and associated staff 

will read and analyze all responses 

received, and use them, in addition to 

its own background work, to develop a 

report on these topics to inform NSF 

and the community. It intends to 

publish this report by the end of 2018. 

The AC ERE also anticipates making 

submissions publicly accessible through 

its website (https://www.nsf.gov/ere/ 

ereweb/advisory.jsp). Authors who do 

not wish to have their full responses 

posted online may restrict access to the 

AC ERE and associated staff. However, 


sradovich on DSK3GMQ082PROD with NOTICES